Herman Sullivan MD MD (He/Him)
Neuroimmunology/Multiple Sclerosis
Executive Medical Director Hauenstein Neurosciences Medical Director, Multiple Sclerosis Clinic at Trinity Health GR
Join to View Full Profile
200 Cherry St SEGrand Rapids, MI 49503
Phone+1 616-685-5050
Dr. Sullivan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Herman Sullivan is a neurologist based in Grand Rapids, MI, specializing in Neuroimmunology/Multiple Sclerosis, and is proficient in general neurology, clinical research, biomedical research, and neuroimmunology. He completed his internship in Internal Medicine at The MetroHealth System/Case Western Reserve University, his Neurology Residency at Case Western Reserve University and Neuroscience Research Fellowship at Stanford University Medical Center respectively. Dr. Sullivan serves as a Clinical Associate Professor at Michigan State University Human College of Medicine, Executive Medical Director of the Hauenstein Neuroscience Center Trinity Health Grand Rapids, as well the Medical Director of the MS Clinic. He has published multiple notable research papers in his field, particularly focused on the treatment of multiple sclerosis. He has also engaged in clinical trials revolving around treatments for multiple sclerosis.
Education & Training
Stanford Health CareFellowship, 1989 - 1991
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 1986 - 1989
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1985 - 1986
University of North Carolina at Chapel Hill School of MedicineClass of 1985
Harvard UniversityBS, Biochemical Sciences and Molecular Biology, 1977 - 1981
Certifications & Licensure
MI State Medical License 1996 - 2025
OH State Medical License 1991 - 1996
CA State Medical License 1989 - 1991
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis Start of enrollment: 2005 Apr 01
- Clinical Trial Nuedexta in Subjects With ALS Start of enrollment: 2013 Apr 01
- Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409 Start of enrollment: 2015 Jan 07
- Join now to see all
Publications & Presentations
PubMed
- 190 citationsAlemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical TrialAlasdair Coles, Edward Fox, A. Vladic, Suzanne Gazda, Vesna V. Brinar
Neurology. 2012-04-03 - 39 citationsA single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosisEdward Fox, H. C. Sullivan, Suzanne Gazda, Lori Mayer, L. O'Donnell
European Journal of Neurology. 2012-02-01 - 107 citationsLinomide in relapsing and secondary progressive MS Part II: MRI resultsJerry S. Wolinsky, Ponnada A. Narayana, John H. Noseworthy, Fred D. Lublin, John N. Whitaker
Neurology. 2000-05-09
Professional Memberships
- Member
- Member
- Member
Industry Relationships
- Medical Director, Pharmcia & UpjohnMedical director for several chemical entities in various stages of development, including pramipexole (Parkinson disease), almotriptan (migraine), and linomide (multiple sclerosis).Disclosure: None currently1995 - 1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
